129 related articles for article (PubMed ID: 5769733)
1. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
Bochner F; Lloyd HM; Roeser HP; Thomas MJ
Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
[No Abstract] [Full Text] [Related]
2. Amino-glutethimide (elipten) in adenocortical carcinoma.
Miranda-Zetterstrand N; Díaz-Bonet L; Pagán-Sáez H; Rosaly de Jirau W
Bol Asoc Med P R; 1968 Dec; 60(12):611-8. PubMed ID: 5253414
[No Abstract] [Full Text] [Related]
3. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
Philbert M; Laudat MH; Laudat P; Bricaire H
Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
[No Abstract] [Full Text] [Related]
4. Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients.
Hutter AM; Kayhoe DE
Am J Med; 1966 Oct; 41(4):581-92. PubMed ID: 5923599
[No Abstract] [Full Text] [Related]
5. [Inhibition of adrenocortical steroid production in therapy].
Bricaire H; Philbert M; Luton JP
Rev Fr Etud Clin Biol; 1968; 13(6):563-7. PubMed ID: 4178146
[No Abstract] [Full Text] [Related]
6. [Clinical experiences with aminoglutethimide (Elipten), a new inhibitor of steroid biosynthesis in the adrenal gland].
Horký K; Küchel O; Gregorová I; Jiránková J; Matys Z
Schweiz Med Wochenschr; 1968 Nov; 98(47):1843-51. PubMed ID: 4236505
[No Abstract] [Full Text] [Related]
7. o,p'DDD therapy in invasive adrenocortical carcinoma.
Becker D; Schumacher OP
Ann Intern Med; 1975 May; 82(5):677-9. PubMed ID: 1137262
[TBL] [Abstract][Full Text] [Related]
8. A case of adrenocortical cancer treated with O,P'-DDD.
Sakauchi N; Kumaoka S; Naruke T; Abe O; Kusama M
Endocrinol Jpn; 1969 Apr; 16(2):287-90. PubMed ID: 5819718
[No Abstract] [Full Text] [Related]
9. Aminoglutethimide in functioning adrenal carcinoma: case report.
Kumar RS; Kamitsuna S; Cole VW
South Med J; 1969 Feb; 62(2):225-7. PubMed ID: 5766457
[No Abstract] [Full Text] [Related]
10. Steroids in urine from a patient with adrenocortical carcinoma after treatment with op'-DDD.
Gustafsson JA; Lisboa BP
Steroidologia; 1971; 2(1):27-37. PubMed ID: 5133742
[No Abstract] [Full Text] [Related]
11. The treatment of congenital adrenal hyperplasia with aminoglutethimide.
Hamilton W
Q J Med; 1971 Oct; 40(160):568-9. PubMed ID: 5157412
[No Abstract] [Full Text] [Related]
12. [Use of elipten in Itsenko-Cushing disease (preliminary report)].
Marova EI; Lemesheva SN
Probl Endokrinol (Mosk); 1970; 16(5):7-10. PubMed ID: 5520275
[No Abstract] [Full Text] [Related]
13. Aminoglutethimide: a "side-effect" turned to therapeutic advantage.
Hughss SW; Burley DM
Postgrad Med J; 1970 Jul; 46(537):409-16. PubMed ID: 4920933
[TBL] [Abstract][Full Text] [Related]
14. Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
Givens JR; Camacho A; Patterson P
Metabolism; 1970 Oct; 19(10):818-30. PubMed ID: 4918596
[No Abstract] [Full Text] [Related]
15. Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism.
McMillan M; Maisey MN
Acta Endocrinol (Copenh); 1970 Aug; 64(4):676-86. PubMed ID: 4318105
[No Abstract] [Full Text] [Related]
16. Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome.
Schteingart DE; Cash R; Conn JW
JAMA; 1966 Nov; 198(9):1007-10. PubMed ID: 5953457
[No Abstract] [Full Text] [Related]
17. Topical aminoglutethimide and sebum excretion.
Burton JL; Cartlidge M; Shuster S
Br J Dermatol; 1971 Oct; 85(4):400-1. PubMed ID: 4256642
[No Abstract] [Full Text] [Related]
18. Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD.
Helson L; Wollner N; Murphy ML; Schwartz MK
Clin Chem; 1971 Dec; 17(12):1191-3. PubMed ID: 4330217
[No Abstract] [Full Text] [Related]
19. [The effect of eliptene aminoglutethimide on the excretion of gonadotropins and phenol steroids (preliminary study)].
Dil'man VM; Krylova NV; Tsyrlina EV; Vishnevskiĭ AS
Vopr Onkol; 1969; 15(3):94-5. PubMed ID: 5406696
[No Abstract] [Full Text] [Related]
20. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD).
Schechter RD; Stabenfeldt GH; Gribble DH; Ling GV
J Am Vet Med Assoc; 1973 Apr; 162(8):629-39. PubMed ID: 4697358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
